AU2002224074A1 - Drugs and foods improving the quality of life and process for producing the same - Google Patents

Drugs and foods improving the quality of life and process for producing the same

Info

Publication number
AU2002224074A1
AU2002224074A1 AU2002224074A AU2407402A AU2002224074A1 AU 2002224074 A1 AU2002224074 A1 AU 2002224074A1 AU 2002224074 A AU2002224074 A AU 2002224074A AU 2407402 A AU2407402 A AU 2407402A AU 2002224074 A1 AU2002224074 A1 AU 2002224074A1
Authority
AU
Australia
Prior art keywords
drugs
life
producing
quality
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224074A
Inventor
Kunio Ando
Akio Fukuda
Kazuo Igusa
Juri Kawai
Toshichika Ogasawara
Seikichi Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuclear Receptor Ligand Co Ltd
Original Assignee
Nuclear Receptor Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuclear Receptor Research Ltd filed Critical Nuclear Receptor Research Ltd
Publication of AU2002224074A1 publication Critical patent/AU2002224074A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
AU2002224074A 2000-11-24 2001-11-22 Drugs and foods improving the quality of life and process for producing the same Abandoned AU2002224074A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-357573 2000-11-24
JP2000357573A JP4592041B2 (en) 2000-11-24 2000-11-24 New food production methods and applications that improve quality of life
PCT/JP2001/010212 WO2002041912A1 (en) 2000-11-24 2001-11-22 Drugs and foods improving the quality of life and process for producing the same

Publications (1)

Publication Number Publication Date
AU2002224074A1 true AU2002224074A1 (en) 2002-06-03

Family

ID=18829612

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224074A Abandoned AU2002224074A1 (en) 2000-11-24 2001-11-22 Drugs and foods improving the quality of life and process for producing the same

Country Status (8)

Country Link
US (1) US20040018190A1 (en)
EP (1) EP1350519A1 (en)
JP (1) JP4592041B2 (en)
KR (1) KR20030074625A (en)
CN (1) CN1481253A (en)
AU (1) AU2002224074A1 (en)
CA (1) CA2429649A1 (en)
WO (1) WO2002041912A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1466621A4 (en) * 2001-12-28 2009-05-27 Nrl Pharma Inc Compositions for improving lipid metabolism
US8399414B2 (en) * 2002-01-21 2013-03-19 Nrl Pharma, Inc. Analgesics
AU2003291206A1 (en) 2002-12-04 2004-06-23 Agennix Incorporated Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease
WO2004054608A2 (en) * 2002-12-12 2004-07-01 Agennix Incorporated Lactoferrin in the reduction of pain
WO2004103285A2 (en) * 2003-05-14 2004-12-02 Agennix Incorporated Lactoferrin in the treatment of diabetes mellitus
WO2005025609A1 (en) * 2003-09-10 2005-03-24 Nrl Pharma, Inc. Lactoferrin material composition
US20060013890A1 (en) * 2004-06-24 2006-01-19 Green Shawn J Dairy-derived anticholesterol immunoglobulin to lower dietary cholesterol in humans
AT502098B8 (en) 2004-07-07 2007-06-15 Albert Dr Missbichler DIAMOND OXIDASE-CONTAINING COMPOSITION
US7183381B2 (en) 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof
KR100643223B1 (en) * 2005-03-10 2006-11-10 임재용 Flat Keeper
JPWO2007001006A1 (en) 2005-06-29 2009-01-22 株式会社Ｎｒｌファーマ Heavy metal disorder ameliorating agent and pharmaceutical composition, food, and cosmetic containing the same
CN102847141A (en) * 2005-09-28 2013-01-02 文特里亚生物科学公司 Oral formulations for enteric disorders and/or rehydration
US20070087002A1 (en) * 2005-10-14 2007-04-19 Green Shawn J Anticholesterol immunoglobulin to treat lipid raft diseases
CN1875748B (en) * 2006-03-15 2011-07-06 杨林伟 Application method of lactoferritin in food
WO2008013455A1 (en) * 2006-07-27 2008-01-31 Lactive B.V. Means and methods for preventing elevated blood glucose levels in humans with animal antibodies produced in milk
JP2008109910A (en) * 2006-10-31 2008-05-15 Toshihiro Nomura Enzyme-compounded granule acting in intestine, and enzyme-compounded food using the enzyme-compounded granule
JP5087297B2 (en) * 2007-03-05 2012-12-05 森永乳業株式会社 Interleukin-11 production promoter
NZ560524A (en) * 2007-08-09 2011-04-29 Fonterra Co Operative Group Treating or preventing rotavirus infection using conjugated linoleic acid
US20090202613A1 (en) * 2008-02-11 2009-08-13 Tabatchnick Fine Foods, Inc. Nutritionally Enhanced Therapeutic Preventative Food Supplement and Method of Making Same
JP5033115B2 (en) * 2008-12-15 2012-09-26 株式会社Ｎｒｌファーマ Novel pharmaceutical composition and processed food for treating or preventing dry eye
US7953829B2 (en) * 2009-02-05 2011-05-31 At&T Mobility Ii Llc System and method for quality of service (QoS) parameter change
DE102009049702A1 (en) * 2009-10-18 2011-04-21 Vczs Venture Capital Zentralschweiz Ag Use of lactoferrin and lactoferrin containing compositions
US20130034541A1 (en) * 2010-04-23 2013-02-07 Probiotec Limited Pharmaceutical compositions
US20120070423A1 (en) * 2010-09-21 2012-03-22 Puneet Nanda Oral composition and method of forming and using same
WO2013085540A2 (en) * 2011-12-09 2013-06-13 The Ohio State University Research Foundation Cry crystals for the production of antimicrobial proteins
TWI434706B (en) 2011-12-15 2014-04-21 Ind Tech Res Inst Enterosoluble and intestinal-enzyme-biodegradable materials and method for preparing the same
WO2014036564A1 (en) * 2012-08-31 2014-03-06 Dr. Fresh, Llc Oral care composition for promoting and maintaining oral health and method of forming and using same
JP6327626B2 (en) 2013-04-09 2018-05-23 国立大学法人 東京大学 Inhibitors of leukocyte extracellular trap formation
CN105517539A (en) 2013-08-21 2016-04-20 Nrl制药股份有限公司 Method for producing microparticles
ITMI20131578A1 (en) * 2013-09-25 2015-03-26 Giellepi S P A SUBSTANCE AND FORMULATION FOR THE TREATMENT OF CHRONIC INTESTINAL INFLAMMATORY DISEASES
US10631564B2 (en) 2015-06-19 2020-04-28 University Of Southern California Enterically coated microparticle compositions and methods for modified nutrient delivery
US10744070B2 (en) 2015-06-19 2020-08-18 University Of Southern California Enteral fast access tract platform system
EP3854412A4 (en) * 2018-09-20 2022-06-15 NRL Pharma, Inc. Agent and composition for improving intrauterine bacterial flora, and method for determining whether intrauterine bacterial flora has been improved or normalized
JP7339057B2 (en) * 2019-08-06 2023-09-05 ライオン株式会社 Enteric-coated tablet containing lactoferrin and method for producing the same
JP7370224B2 (en) * 2019-11-08 2023-10-27 ライオン株式会社 Enteric-coated preparation containing lactoferrin
CN117462657A (en) * 2023-11-13 2024-01-30 广州见华医学科技有限公司 Application of lactoferrin capsule in bacteriostasis and anti-inflammation

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60221078A (en) * 1984-04-18 1985-11-05 Morinaga Milk Ind Co Ltd Granular product of useful microorganism powder and its preparation
HU207452B (en) * 1986-03-21 1993-04-28 Eurasiam Lab Method for producing therapeutical preparations containing active ingredient having biologicallu active protein structure
JPS6351337A (en) * 1986-08-22 1988-03-04 Snow Brand Milk Prod Co Ltd Antitumor agent
JPH0764723B2 (en) * 1986-10-15 1995-07-12 鐘紡株式会社 Method for manufacturing enteric coated drug
JPH0779684B2 (en) * 1989-02-27 1995-08-30 森永乳業株式会社 Bifidobacteria growth promoting composition
DK469989D0 (en) * 1989-09-22 1989-09-22 Bukh Meditec PHARMACEUTICAL PREPARATION
JP3184923B2 (en) * 1992-01-08 2001-07-09 ビオ セレ ラボラトワール エス ア Anti-rheumatic drug
JPH05186337A (en) * 1992-01-09 1993-07-27 Kanebo Ltd Enteric granule composed of multiple granules
JPH05279266A (en) * 1992-04-02 1993-10-26 Imuno Japan:Kk Medicine composition for treating and preventing periodontosis
DE69432309D1 (en) * 1993-09-20 2003-04-24 Anadis Ltd METHOD FOR PRODUCING IMMUNOGLOBULINES FROM COLOSTRUM AND THE USE THEREOF IN PHARMACEUTICAL COMPOSITIONS
JPH07316069A (en) * 1994-05-24 1995-12-05 Tokushu Meneki Kenkyusho:Kk Composition for preventing and treating opportunistic infection
JPH08253423A (en) * 1995-01-19 1996-10-01 Tokushu Meneki Kenkyusho:Kk Food and medicinal granule containing lactoferrin and their production
US20020016289A1 (en) * 1995-06-01 2002-02-07 Orla M. Conneely Methods for treatment and prevention of helicobacter pylori infection using lactoferrin
JP3859270B2 (en) * 1996-07-26 2006-12-20 森永乳業株式会社 Apoptosis inducer
JP4233615B2 (en) * 1996-08-22 2009-03-04 森永乳業株式会社 Oral anti-human onychomycosis and / or pharmaceuticals for human foot ringworm other than onychomycosis
JPH10108630A (en) * 1996-10-04 1998-04-28 Showa Sangyo Co Ltd Lustering coating agent for food having good workability at the time of coating
WO1998030235A1 (en) * 1997-01-09 1998-07-16 Morinaga Milk Industry Co., Ltd. Lactoferrin tablets
KR19990072826A (en) * 1998-02-26 1999-09-27 우재영 A process for producing enteric-coated pancreatin granules
WO2000006192A1 (en) * 1998-07-30 2000-02-10 Morinaga Milk Industry Co., Ltd. Liver function ameliorating agents
AU1071200A (en) * 1998-10-19 2000-05-08 Biotech Australia Pty Limited Systems for oral delivery
JP2002535271A (en) * 1999-01-21 2002-10-22 エラン コーポレーシヨン ピーエルシー Multiparticulate bisoprolol formulation
JP2000229881A (en) * 1999-02-10 2000-08-22 Morinaga Milk Ind Co Ltd Prognosis-improving agent for cancerous disease
JP4014330B2 (en) * 1999-03-31 2007-11-28 雪印乳業株式会社 Viral infection protection agent
JP4151872B2 (en) * 1999-08-09 2008-09-17 森永乳業株式会社 Enteric-coated sugar-coated tablets

Also Published As

Publication number Publication date
JP4592041B2 (en) 2010-12-01
US20040018190A1 (en) 2004-01-29
CA2429649A1 (en) 2002-05-30
KR20030074625A (en) 2003-09-19
WO2002041912A1 (en) 2002-05-30
EP1350519A1 (en) 2003-10-08
CN1481253A (en) 2004-03-10
JP2002161050A (en) 2002-06-04

Similar Documents

Publication Publication Date Title
AU2002224074A1 (en) Drugs and foods improving the quality of life and process for producing the same
AU4467801A (en) Chlamydospores and process for producing the same
AU2001252569A1 (en) Fermented foods and process for producing the same
AU2003233010A1 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
AU2882201A (en) Sustained-release preparation and process for producing the same
AU5679999A (en) Process for the production of masa flour
AU2000273206A1 (en) Photocatalyst-bearing material and method of producing the same
AU2003266587A1 (en) Enzyme preparation and process for producing food using the same
AU2001274625A1 (en) Hollow cakes containing puffed chocolate and process for producing the same
AU1306601A (en) Chemically modified supports and process for producing the same
AU2001283984A1 (en) Process for the production of seats and furnishings elements and seats and furnishings elements so obtained
AU2001214181A1 (en) Mayonnaise-like foods and process for producing the same
AU1418101A (en) Mayonnaise-like foods and process for producing the same
AU1334801A (en) Low density marshmallow-like products and methods of producing the same
AU2000234588A1 (en) Process for producing lipids and lipid-secreting microorganisms
AU2000234587A1 (en) Process for producing lipids and lipid-secreting microorganisms
AU2002237253A1 (en) Biosensor and method of producing the same
AU2001272757A1 (en) Process for producing 5-fluorooxyindole and for producing intermediate therefor
AU2002242685A1 (en) Creamy foodstuff and method for production thereof
AU2002229149A1 (en) Process for producing hydrazinomonosaccharide derivatives and use thereof
AU2001274004A1 (en) Method for the production of 2- coumarone and substituted 2-coumarones
EP1374702A4 (en) Flavor materials and process for producing the same
AU1894501A (en) Process for producing tofu-like food material
AU2002216364A1 (en) Novel substance fki-1083 and process for producing the same
AU2000228300A1 (en) Novel substance fki-0076 and process for producing the same